nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
|
Hess, Paul L. |
|
2014 |
168 |
3 |
p. 239-247.e1 2232 p. |
artikel |
2 |
Assessment of side branch predilation before a provisional T-stent strategy for bifurcation lesions. A randomized trial
|
Pan, Manuel |
|
2014 |
168 |
3 |
p. 374-380 7 p. |
artikel |
3 |
Cardiac Safety Research Consortium: Can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward
|
Darpo, Borje |
|
2014 |
168 |
3 |
p. 262-272 11 p. |
artikel |
4 |
Cardiac troponin I levels in patients with non–ST-elevation acute coronary syndrome—The importance of gender
|
Eggers, Kai M. |
|
2014 |
168 |
3 |
p. 317-324.e1 2924 p. |
artikel |
5 |
Clopidogrel prescription filling delays and cardiovascular outcomes in a pharmacy system integrating inpatient and outpatient care: Insights from the Veterans Affairs CART Program
|
Byrd, James B. |
|
2014 |
168 |
3 |
p. 340-345 6 p. |
artikel |
6 |
Current quality of cardiovascular prevention for Million Hearts: An analysis of 147,038 outpatients from The Guideline Advantage
|
Eapen, Zubin J. |
|
2014 |
168 |
3 |
p. 398-404 7 p. |
artikel |
7 |
Diagnostic accuracy of multidetector computed tomography coronary angiography in 325 consecutive patients referred for transcatheter aortic valve replacement
|
Andreini, Daniele |
|
2014 |
168 |
3 |
p. 332-339 8 p. |
artikel |
8 |
Editorial Board
|
|
|
2014 |
168 |
3 |
p. A4- 1 p. |
artikel |
9 |
Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
|
Goto, Shinya |
|
2014 |
168 |
3 |
p. 303-309 7 p. |
artikel |
10 |
Electrocardiographic abnormalities and coronary artery calcium for coronary heart disease prediction and reclassification: The Multi-Ethnic Study of Atherosclerosis (MESA)
|
Desai, Chintan S. |
|
2014 |
168 |
3 |
p. 391-397 7 p. |
artikel |
11 |
Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentations
|
Loh, Joshua P. |
|
2014 |
168 |
3 |
p. 248-255 8 p. |
artikel |
12 |
Information for Readers
|
|
|
2014 |
168 |
3 |
p. A5- 1 p. |
artikel |
13 |
Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
|
Bradley, Steven M. |
|
2014 |
168 |
3 |
p. 381-390.e6 3.8999962E8 p. |
artikel |
14 |
Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: The randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) study
|
Ofstad, Anne Pernille |
|
2014 |
168 |
3 |
p. 280-288.e2 28521 p. |
artikel |
15 |
Parathyroid hormone concentration and risk of cardiovascular diseases: The Atherosclerosis Risk in Communities (ARIC) study
|
Folsom, Aaron R. |
|
2014 |
168 |
3 |
p. 296-302 7 p. |
artikel |
16 |
Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: Rationale and design of the BIOSCIENCE trial
|
Pilgrim, Thomas |
|
2014 |
168 |
3 |
p. 256-261 6 p. |
artikel |
17 |
Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: A meta-analysis of individual patient data
|
Fokkema, Marieke L. |
|
2014 |
168 |
3 |
p. 354-362.e2 35847 p. |
artikel |
18 |
Spironolactone lowers the rate of repeat revascularization in acute myocardial infarction patients treated with percutaneous coronary intervention
|
Song, Pil Sang |
|
2014 |
168 |
3 |
p. 346-353.e3 352655 p. |
artikel |
19 |
Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention
|
Tully, Lisa |
|
2014 |
168 |
3 |
p. 310-316.e3 315691 p. |
artikel |
20 |
Table of Contents
|
|
|
2014 |
168 |
3 |
p. A1-A3 nvt p. |
artikel |
21 |
Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008
|
Patel, Hiren |
|
2014 |
168 |
3 |
p. 363-373.e12 3.72999999999638E14 p. |
artikel |
22 |
The role of primary care physician and cardiologist follow-up for low-risk patients with chest pain after emergency department assessment
|
Czarnecki, Andrew |
|
2014 |
168 |
3 |
p. 289-295 7 p. |
artikel |
23 |
The use of aortic counterpulsation in United States: What can we learn from administrative databases?
|
McDonough, Ryan |
|
2014 |
168 |
3 |
p. 237-238 2 p. |
artikel |
24 |
Type of β-blocker use among patients with versus without diabetes after myocardial infarction
|
Arnold, Suzanne V. |
|
2014 |
168 |
3 |
p. 273-279.e1 2518 p. |
artikel |
25 |
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation
|
Sartipy, Ulrik |
|
2014 |
168 |
3 |
p. 325-331 7 p. |
artikel |